Open AccessRandomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer
Author(s) -
Mark A. Socinski,
Robert N. Raju,
Thomas E. Stinchcombe,
Darren M. Kocs,
Linda S. Couch,
David Barrera,
Steven R. Rousey,
J. K. Choksi,
Robert M. Jotte,
Debra A. Patt,
Phillip Periman,
H. R. Schlossberg,
Charles Weissman,
Yunfei Wang,
Lina Asmar,
Sharon Pritchard,
Jane Bromund,
Guangbin Peng,
Joseph Treat,
Coleman K. Obasaju
Publication year - 2010
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/pj45-e975
Subject(s) - carboplatin , pemetrexed , docetaxel , medicine , oncology , lung cancer , chemotherapy , cisplatin